药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levorphanol
Paliperidone
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Paliperidone.
Levorphanol
Halofantrine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Halofantrine.
Levorphanol
Encorafenib
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Encorafenib.
Levorphanol
Emedastine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Emedastine.
Levorphanol
Ondansetron
The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lapatinib.
Levorphanol
Dexverapamil
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dexverapamil.
Levorphanol
Penfluridol
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Penfluridol.
Levorphanol
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dexchlorpheniramine.
Levorphanol
Lorcainide
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lorcainide.
Levorphanol
Bunaftine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bunaftine.
Levorphanol
Nizofenone
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nizofenone.
Levorphanol
Otilonium
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Otilonium.
Levorphanol
Sultopride
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sultopride.
Levorphanol
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Sitafloxacin.
Levorphanol
Oxatomide
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Oxatomide.
Levorphanol
Abexinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Abexinostat.
Levorphanol
Mizolastine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mizolastine.
Levorphanol
Ricolinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ricolinostat.
Levorphanol
Simendan
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Simendan.
Levorphanol
CUDC-101
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with CUDC-101.